| Value | ₹373.9 Cr |
|---|
BSE filing, NSE: PHOENIXLTD. Summary written from the filing by ALFA Finder's alert engine.
Phoenix Mills Ltd: key numbers
- Share price
- ₹2,242.30
- Market cap
- ₹80,205 Cr
- Revenue (annual)
- ₹4,423 Cr
- Net profit (annual)
- ₹1,224 Cr
- P/E (TTM)
- 61.6×Sector 35.7×
- Promoter holding
- 47.24%-0.01% QoQ
- FII holding
- 31.62%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Phoenix Mills Ltd
All →Phoenix Mills Employee Stock Options
Phoenix Mills allotted 9,734 equity shares to employees under its ESOP 2018 scheme on 17 November 2026. Paid-up capital rises to Rs 71.54 Crore across 35,77,01,888 shares.
Phoenix Mills Acquisition Worth ₹1,350 Cr
Phoenix Mills completed the NCLT-approved selective capital reduction in ISMDPL, paying CPP Investments ₹1,350 Crore. Its stake in ISMDPL rose from 58.33% to 68.10%.
- Value
- ₹1,350 Cr
Phoenix Mills Earnings Call Transcript: Key Takeaways
Phoenix Mills delivered a robust quarter led by 25% retail consumption growth and office occupancy scale-up. Management is prioritizing asset densification and strategic churn to reset rental bases.
Phoenix Mills Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue Rs. 1,153 cr (+3%), EBITDA Rs. 710 cr (+7%), PAT Rs. 424 cr (+11%). Annuity PAT +31% drives mix shift away from residential.
Phoenix Mills Q2 FY27 Results: Net Profit ₹427 Cr, Up 11.2% YoY
Phoenix Mills Ltd reported revenue from operations of ₹1,153 Cr (+3.4% YoY) and net profit of ₹427 Cr (+11.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹427 Cr · +11.2% YoY
Phoenix Mills Acquisition Worth ₹1,350 Cr
NCLT Mumbai approved Island Star Mall Developers' Rs 1,350 Crore buyback of CPP Investments' shares. Phoenix Mills' stake in the subsidiary rises from 58.33% to 68.10%.
- Value
- ₹1,350 Cr
- Execution
- Consideration to be paid within 30 days of filing the certified NCLT order with the Registrar of Companies
Other acquisition announcements
All →Piramal Pharma Acquisition
Piramal Pharma exercised a call option to acquire the remaining 26% stake in subsidiary Yapan Bio. Final consideration and transfer date are yet to be finalised.
Advent Hotels International Acquisition Worth ₹5.38 Cr
Advent Hotels acquired 50% control of Advent Convention and Hotels International Pvt Ltd for Rs.5.38 Crore cash. The target will develop a Mumbai commercial project.
- Value
- ₹5.38 Cr
- Execution
- Indicative completion date stated as 17-11-2026
AYM Syntex Acquisition
NCLT Mumbai sanctioned the amalgamation of Mandawewala Enterprises into AYM Syntex, effective on sanction. The formal order is awaited and will be disclosed when received.
ACCEL Acquisition Worth ₹3.01 Cr
Accel will buy 2,98,399 Secureinteli shares at ₹101 each, lifting its stake to 84.10%. Secureinteli becomes a subsidiary, a deal worth about ₹3.01 Crore.
- Value
- ₹3.01 Cr
Prestige Estates Projects Acquisition Worth ₹2.69 Cr
Prestige's subsidiary acquired 50% of Advent Convention for ₹2.69 Crore. The target holds 21,978 sq. m land in Mumbai for a ₹4,500 Crore commercial project.
- Value
- ₹2.69 Cr
- leasable area
- 1500000 sq. ft.
Insecticides (India) Acquisition Worth ₹3.54 Cr
Insecticides (India) invested Rs. 3.54 Crore for a 26% stake in FP Alpha Private Limited. The acquisition targets wind and solar captive power capacity in Gujarat.
- Value
- ₹3.54 Cr